SciVision Biotech Inc
TWSE:1786
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
74.4
136.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SciVision Biotech Inc stock under the Base Case scenario is 178.54 TWD. Compared to the current market price of 90.4 TWD, SciVision Biotech Inc is Undervalued by 49%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
SciVision Biotech Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SciVision Biotech Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
SciVision Biotech Inc
Balance Sheet Decomposition
SciVision Biotech Inc
Current Assets | 1B |
Cash & Short-Term Investments | 782.4m |
Receivables | 129.6m |
Other Current Assets | 105.1m |
Non-Current Assets | 1.1B |
Long-Term Investments | 50k |
PP&E | 1.1B |
Intangibles | 1.8m |
Other Non-Current Assets | 8.9m |
Current Liabilities | 123.4m |
Accounts Payable | 14.1m |
Other Current Liabilities | 109.3m |
Non-Current Liabilities | 198.2m |
Long-Term Debt | 159m |
Other Non-Current Liabilities | 39.2m |
Earnings Waterfall
SciVision Biotech Inc
Revenue
|
831.4m
TWD
|
Cost of Revenue
|
-209.7m
TWD
|
Gross Profit
|
621.7m
TWD
|
Operating Expenses
|
-372.6m
TWD
|
Operating Income
|
249.1m
TWD
|
Other Expenses
|
-33.1m
TWD
|
Net Income
|
216m
TWD
|
Free Cash Flow Analysis
SciVision Biotech Inc
TWD | |
Free Cash Flow | TWD |
Profitability Score
Profitability Due Diligence
SciVision Biotech Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Score
SciVision Biotech Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
SciVision Biotech Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
SciVision Biotech Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
SciVision Biotech Inc
Dividends
Current shareholder yield for SciVision Biotech Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one SciVision Biotech Inc stock under the Base Case scenario is 178.54 TWD.
Compared to the current market price of 90.4 TWD, SciVision Biotech Inc is Undervalued by 49%.